Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT06903377 · RECRUITING
Trial details
- NCT number
- NCT06903377
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-23
- Primary completion
- 2027-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.